Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A phase 1, randomised, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study to evaluate the safety, tol… Ended

2023-506912-41-00 Idiopathic pulmonary fibrosis 3 2024-01-09
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Intensive Care 5 2023-12-20
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors Ended

2022-502348-11-00 Pancreatic Neoplasms 1 2023-12-15
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 4-Arm Dose Ranging Study of the Safety and Efficacy of Nalbuphine Extended-Release… Ended

2023-505296-72-00 Idiopathic Pulmonary Fibrosis (IPF) 4 2023-12-12
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended

2023-504487-41-00 COVID-19 5 2023-11-28
A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled … Ended

2022-502854-16-00 Asthma 4 2023-11-26
Efficacy and safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund maintenance therapy Ended

2022-502208-64-00 Asthma 4 2023-11-25
GRemubamab ErAdication Trial (GREAT-2) Ended

2022-502494-41-00 bronchiectasis and chronic Pseudomonas aeruginosa infec 4 2023-11-21
A study on the immune response and safety of an RSV vaccine when given to adults 18 years of age and above who received lung or kidney trans… Ended

2023-503951-81-00 Respiratory Syncytial Virus Infections 4 2023-11-07
A Phase 2 Safety and Immunogenicity Study of a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers Ended

2023-505154-18-00 Pneumococcal Infections 4 2023-11-02
A Study to Investigate MBS2320 Patients with IPF Ended

2023-504418-30-00 Idiopathic Pulmonary Fibrosis 4 2023-10-24
An open-label, healthy subject, two-part study to assess the effect of verapamil on systemic exposure of EP395 (Part A), and to assess the e… Ended

2023-506345-34-00 Chronic obstructive pulmonary disease (COPD) 3 2023-10-23
A Study to Evaluate the Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters in Participants with COPD Ended

2022-502274-16-00 Chronic Obstructive Pulmonary Disease 11 2023-10-19
Comparison of multiple doses of intramuscular versus intranasal naloxone for reversal of opioid toxicity Ended

2023-505338-93-00 Healthy volunteers 4 2023-09-21
Randomised, crossover bioequivalence clinical trial of montelukast 10 mg capsules vs montelukast 10 mg film-coated tablets, after a single o… Ended

2023-506937-30-00 Asthma 2 2023-09-20
Maternal determinants of infant immunity to pertussis (MADI-02) Ended

2024-517893-73-00 Whooping cough 6 2023-09-09
A phase II, randomized, double-blind, multi-centre trial to evaluate the safety and immunogenicity of BIMERVAX® when coadministered with sea… Ended

2023-506189-29-00 SARS-CoV-2 and Influenza 4 2023-09-04
A Study to Evaluate the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patie… Ended

2022-502828-42-00 Idiopathic Pulmonary Fibrosis 4 2023-09-01
Bioequivalence study between two fluticasone propionate 500μg/salmeterol 50μg inhalation powders Ended

2023-504789-48-00 Healthy volunteers: regular treatment of bronchial ast 2 2023-08-23
A three part randomized, double-blind, placebo-controlled, parallel group SAD and MD clinical study to evaluate the safety, tolerability and… Ended

2023-507203-55-00 Pseudomonas colonization 1 2023-08-21
A phase I study to evaluate an investigational medicinal product for the treatment of asthma, in healthy adult participants. Ended

2023-504326-19-00 Asthma 3 2023-08-03
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended

2022-501020-19-01 COVID-19 5 2023-07-31
Bioequivalence study between two fluticasone propionate 250μg/salmeterol 50μg inhalation powders Ended

2023-505198-34-00 Healthy volunteers.Regular treatment of bronchial asthm 2 2023-07-31
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended

2022-502234-70-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-07-14